Novartis Investigative Site

Pori FIN-28500

0 studies enrolling now · 3 studies all time

What they study most

Chronic Obstructive Pulmonary Disease (COPD), Leukaemia, Lymphocytic, Chronic, Parkinson's Disease

Studies at this site

• Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy — Stopped early
• A Multi-centre Randomized Double Blind 52-week Study to Assess the Safety of QVA149 Compared to QAB149 in Patients With COPD Who Have Moderate to Severe Airflow Limitation — Completed
• Efficacy and Safety of Carbidopa/Levodopa/Entacapone in Patients With Parkinson's Disease Requiring Initiation of Levodopa Therapy — Completed